Monophosphoryl lipid A
Term · Oncology and biomedicine · MLC-T-ONC-015276
A modified form of lipid A, the biologically active part of Gram-negative bacterial lipopolysaccharide (LPS) endotoxin, and a Toll-like receptor 4 (TLR4) agonist, with potential immunostimulatory activity. As a vaccine adjuvant, monophosphoryl lipid A (MPLA) stimulates both cellular and humoral responses to the vaccine antigen. Compared to LPS, MPLA exerts a similar immunostimulatory activity but with reduced toxicity.
| Identifier | MLC-T-ONC-015276 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | MPL |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015276",
"term": "Monophosphoryl lipid A",
"field": "Oncology and biomedicine",
"definition": "A modified form of lipid A, the biologically active part of Gram-negative bacterial lipopolysaccharide (LPS) endotoxin, and a Toll-like receptor 4 (TLR4) agonist, with potential immunostimulatory activity. As a vaccine adjuvant, monophosphoryl lipid A (MPLA) stimulates both cellular and humoral responses to the vaccine antigen. Compared to LPS, MPLA exerts a similar immunostimulatory activity but with reduced toxicity.",
"abbreviation": "MPL",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/monophosphoryl-lipid-a/"
}
Record 11,259 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.